Navigation Links
Human Genome Sciences Initiates First Clinical Trial of Lead IAP Inhibitor HGS1029 in Advanced Solid Tumors
Date:5/30/2008

ectives of the Phase 1 open-label, dose-escalation study are to evaluate the safety and tolerability of HGS1029 as monotherapy in patients with advanced solid tumors, and to select a recommended dose for Phase 2 studies. Secondary objectives include documenting possible anti-tumor activity and determining HGS1029's pharmacokinetic profile. HGS1029 will be administered as a 15-minute infusion once weekly for 3 consecutive weeks followed by a week off. Up to 40 patients will be treated in the study, with 15-20 patients treated in the dose-escalation phase.

About the HGS Oncology Portfolio

HGS is investing strategically to expand and advance its oncology portfolio around its leading expertise in the apoptosis pathway. HGS has initiated new chemotherapy combination trials of HGS-ETR1 (mapatumumab), added the new opportunity to develop and commercialize HGS1029 and other IAP inhibitors, and reacquired the rights to its TRAIL receptor antibodies. HGS-ETR1, the Company's antibody to TRAIL receptor 1, is the most advanced of any product in development that targets the TRAIL apoptosis pathway.

About Human Genome Sciences

The mission of HGS is to apply great science and great medicine to bring innovative drugs to patients with unmet medical needs.

The HGS clinical development pipeline includes novel drugs to treat hepatitis C, lupus, inhalation anthrax, cancer and other immune-mediated diseases. The Company's primary focus is rapid progress toward the commercialization of its two key lead drugs, Albuferon(R) for hepatitis C and LymphoStat-B(R) (belimumab) for lupus. Phase 3 clinical trials of both drugs are ongoing.

ABthrax(TM) (raxibacumab) is in late-stage development for the treatment of inhalation anthrax, and the Company is on track to begin the delivery in fall 2008 of 20,000 doses of ABthrax to the Strategic National Stockpile under a contract entered into with the U.S. Government in June 2006. Other HGS drugs in clinical devel
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Video: New Research Discovers Independent Brain Networks Control Human Walking
2. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
3. Enrollment Begins on Human PK Study for Medidur(TM) FA
4. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
5. Study Confirms Limited Human-To-Human Spread of Avian-Flu Virus in Indonesia in 2006
6. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
7. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
8. Dr. Roger Kenneth Hershline PhD MD, CEO of Global Humanceuticals, Inc. Donates New HIV Drug
9. Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
10. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
11. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... , July 31, 2014 Astellas ... head of corporate and employee communications in the ... Jeff Winton , senior vice president, chief communications ... for developing and leading corporate brand initiatives and ... across North and South America ...
(Date:7/31/2014)... -- Cryoport, Inc. (OTCBB: CYRX) today announced financial results ... Recent Operating Highlights , Achieved ... month period ended June 30, 2014 compared to the ... further expand Cryoport,s global reach using the ,powered by ... Immudex, an immunotherapy and vaccine development services company, to ...
(Date:7/31/2014)... 2014 Nutrastar International Inc. (OTCQB: NUIN; "Nutrastar" ... premium branded consumer products, including commercially cultivated Cordyceps Militaris ... announced the signing of its first distributor for its ... Hubei Province located ... . The contract with the ...
Breaking Medicine Technology:Astellas Hires Industry Veteran Moyra Knight as Head of Corporate and Employee Communications 2Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 2Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 3Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 4Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 5Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 6Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 7Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 8Nutrastar Signs First Distributor for New Cordyceps Powder Solution Product, Expands Reach to Central China 2Nutrastar Signs First Distributor for New Cordyceps Powder Solution Product, Expands Reach to Central China 3Nutrastar Signs First Distributor for New Cordyceps Powder Solution Product, Expands Reach to Central China 4
... Confirm Robust Efficacy of CIMZIA, BOSTON, Nov. ... new,Phase III data from the RAPID 1 and ... Annual Scientific Meeting (ACR), which show,CIMZIA(R) (certolizumab pegol), ... Factor), given with methotrexate, is significantly,more effective than ...
... Fla., Nov. 7 A new analysis,presented today ... Evaluation Of Rosuvastatin) showed CRESTOR(R) (rosuvastatin calcium) 40,mg ... in four,patient populations at varying levels of risk ... subjects defined by the Framingham risk,assessment tool as ...
Cached Medicine Technology:CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year 2CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year 3CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year 4CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year 5CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year 6CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year 7CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year 8New Analysis of METEOR Study Demonstrate Effects of AstraZeneca's CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease 2New Analysis of METEOR Study Demonstrate Effects of AstraZeneca's CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease 3New Analysis of METEOR Study Demonstrate Effects of AstraZeneca's CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease 4New Analysis of METEOR Study Demonstrate Effects of AstraZeneca's CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease 5New Analysis of METEOR Study Demonstrate Effects of AstraZeneca's CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease 6
(Date:7/31/2014)... Ethane Web Technologies, an ISO ... new service named ‘Java Development’. The service cost ... designed the service after doing a serious study ... service being provided by other web development companies. ... promise outstanding Java Development service. ...
(Date:7/31/2014)... for anyone, but for those with periodontal disease related to ... smiling. In a report appearing in the August 2014 issue ... one of the most important blood cells involved in the ... and bone loss in type 2 diabetes-associated periodontal disease. ... responses of B cells may treat or prevent this complication. ...
(Date:7/31/2014)... 2014 Healthpointe Medical Group, one ... maintaining the highest standards in health and safety ... is offering Occupational Medicine Services at ... patients. They also accept workers’ compensation cases and ... Medicine services include, but are not limited to, ...
(Date:7/31/2014)... 31, 2014 FORT LAUDERDALE, FLORIDA ... a leading US Joint Commission Accredited teleradiology and ... and technologically advanced consumer storage and sharing platform ... is providing valued members the use of its ... services already offered by SecondOpinions.com®. , Wide-spread ...
(Date:7/31/2014)... New York, NY (PRWEB) July 31, 2014 ... will host its first-ever event in New York on ... Eventi Hotel in Manhattan. , Featuring keynotes by ... Assemblyman Steve Katz (R-Yorktown), the event will include lunch ... Compassionate Care Act and the work NCIA is doing ...
Breaking Medicine News(10 mins):Health News:Ethane Web Technologies Announces Java Development Service at Pocket Friendly Cost 2Health News:Researchers uncover cause of gum disease related to type 2 diabetes 2Health News:Occupational Medicine Services Available at Healthpointe’s Perris Facility 2Health News:SECONDOPINIONS.COM® Introduces Innovative Cloud-Based Medical Imaging Exchange Service for Easy Upload, Access and Sharing Anytime/Anywhere 2Health News:SECONDOPINIONS.COM® Introduces Innovative Cloud-Based Medical Imaging Exchange Service for Easy Upload, Access and Sharing Anytime/Anywhere 3Health News:THURSDAY, AUG 7: First-Ever National Cannabis Industry Association Event in New York Will Feature Senator Savino, Assemblyman Katz, & Industry Leaders 2
... ... v 2.0 which is made up of three products: Semantics.Datacenter, Semantics.Server, and Semantics.Framework. ... industry standard benchmark tests (Berlin 100M 5/25/10). , ... Brattleboro, VT (PRWEB) June 17, 2010 -- ...
... ... Service; Simplicity, Security Benefits IP Telephony Implementation , ... Mississauga, Ontario (PRWEB) June 17, 2010 -- Phybridge ... compliant with key IP Telephony solutions from Avaya, a leading global provider of business ...
... ... a house boating trip at Sunset Marina and Resort. Beautiful Dale Hollow Lake offers ... of Tennessee. , ... Byrdstown, TN (PRWEB) June 17, 2010 -- Families are flocking to the hills of ...
... ... a weekly blog column about Internet Marketing. Paul Hannam will write about hot topics such ... practical strategies and case studies. , ... (PRWEB) June 17, 2010 -- San Diego-based Bright Green Leadership LLC, ...
... ... Website And Updated Web Hosting Plans That Provide The Resources And Services Needed To ... ... our customer in mind, Hosting Metro is proud to announce the launch of their ...
... ... Community Baby Shower for Philadelphia Mothers-to-be , ... Philadelphia, Pa. (Vocus) June 16, 2010 -- Keystone Mercy Health ... Family Services, Inc., a non-profit organization that provides health services to families, will host ...
Cached Medicine News:Health News:Intellidimension Releases New Version of Semantic Web Technologies 2Health News:Phybridge Network Solution Achieves Avaya “Compliant” Status 2Health News:Phybridge Network Solution Achieves Avaya “Compliant” Status 3Health News:Sunset Marina and Resort on Tennessee's Dale Hollow Lake Provides Affordable Houseboat Vacations for Price-Conscious Families 2Health News:Bright Green Leadership Partners with TriplePundit to Help Businesses Improve Their Green Marketing Online 2Health News:Hosting Metro Releases New Website and Upgraded Pricing Plans For All Web Hosting Packages 2Health News:Hosting Metro Releases New Website and Upgraded Pricing Plans For All Web Hosting Packages 3Health News:More Than 100 Philadelphia Expectant-Mothers and Their Families to Attend Keystone Mercy Health Plan's Community Baby Shower 2
... ventricular drainage set (EVD set) ... for external ventricular drainage. It ... with a ventricular catheter or ... probe from the Aesculap Spiegelberg ...
... The Trippi-Wells and Universal tongs were ... are needed than can be safely provided ... ring. Titanium construction. Kit complete with four ... or four pin application. Skull pins at ...
... neuro and skull base surgery. Complete ... surgery, pediatric neurosurgery, bony defects of ... base regions, neuro trauma. Dedicated neuro/skull ... in one compact kit. MRI and ...
Hand Drill, with two-position Handle, with Jacob three-jaw chuck, wrench-locked for changing twist drills up to 6 mm...
Medicine Products: